Abstract
Nitric oxide (NO) is a potent cell signaling and effector molecule that participates in numerous physiological and pathophysiological events in a variety of cell types and tissues. NO derived from all major isoforms of NO synthase can S-nitrosylate cysteine thiols in target proteins, potentially altering their functional activities in a redox-dependent, cGMP-independent manner. Formation of protein S-nitrosocysteine adducts appears to occur through multiple pathways. Emerging evidence suggests that S-nitrosylation is a specific, reversible and regulated covalent post-translational modifi-cation that modulates diverse biological and physiological functions. In addition to altering protein activity, localization and stability, S-nitrosylation participates in the control of cellular metabolism, apoptosis, protein – protein interactions, transcription factor function, ion channel activity and cellular redox balance. Increasingly sophisticated proteomic ap-proaches used in various cell types and tissues have identified S-nitrosylation of proteins of virtually all major classes, in-cluding cytoskeletal proteins, chaperones, proteins of the translational and transcriptional machinery, vesicular transport and signaling. S-nitrosylation has also been shown to regulate the NO synthase isoforms themselves, reversibly inhibiting endothelial NO synthase activity and feedback inhibiting PARP-1, a transactivator of inducible NO synthase. Imbalances in NO metabolism and dysregulated S-nitrosylation have been implicated in a growing list of human diseases, such as neurodegenerative disorders, endotoxemic shock and insulin resistance. Here we review the key discoveries and directions in this field, including the role of S-nitrosylation as a potential therapeutic target in specific human diseases.
Keywords: NO synthase, S-Nitrosoproteome, NADPH, Diabetes Mellitus, Neurodegenerative Diseases, Pulmonary Diseases
Current Genomics
Title: S-Nitrosylation: Targets, Controls and Outcomes
Volume: 7 Issue: 5
Author(s): Bruce C. Kone
Affiliation:
Keywords: NO synthase, S-Nitrosoproteome, NADPH, Diabetes Mellitus, Neurodegenerative Diseases, Pulmonary Diseases
Abstract: Nitric oxide (NO) is a potent cell signaling and effector molecule that participates in numerous physiological and pathophysiological events in a variety of cell types and tissues. NO derived from all major isoforms of NO synthase can S-nitrosylate cysteine thiols in target proteins, potentially altering their functional activities in a redox-dependent, cGMP-independent manner. Formation of protein S-nitrosocysteine adducts appears to occur through multiple pathways. Emerging evidence suggests that S-nitrosylation is a specific, reversible and regulated covalent post-translational modifi-cation that modulates diverse biological and physiological functions. In addition to altering protein activity, localization and stability, S-nitrosylation participates in the control of cellular metabolism, apoptosis, protein – protein interactions, transcription factor function, ion channel activity and cellular redox balance. Increasingly sophisticated proteomic ap-proaches used in various cell types and tissues have identified S-nitrosylation of proteins of virtually all major classes, in-cluding cytoskeletal proteins, chaperones, proteins of the translational and transcriptional machinery, vesicular transport and signaling. S-nitrosylation has also been shown to regulate the NO synthase isoforms themselves, reversibly inhibiting endothelial NO synthase activity and feedback inhibiting PARP-1, a transactivator of inducible NO synthase. Imbalances in NO metabolism and dysregulated S-nitrosylation have been implicated in a growing list of human diseases, such as neurodegenerative disorders, endotoxemic shock and insulin resistance. Here we review the key discoveries and directions in this field, including the role of S-nitrosylation as a potential therapeutic target in specific human diseases.
Export Options
About this article
Cite this article as:
C. Kone Bruce, S-Nitrosylation: Targets, Controls and Outcomes, Current Genomics 2006; 7 (5) . https://dx.doi.org/10.2174/138920206778604340
DOI https://dx.doi.org/10.2174/138920206778604340 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effects of Erythropoietin on the Respiratory Function: Measurements of Respiratory Mechanics in the Rat
Current Respiratory Medicine Reviews Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design TRP Channels in Respiratory Pathophysiology: the Role of Oxidative, Chemical Irritant and Temperature Stimuli
Current Neuropharmacology Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Current Vascular Pharmacology The Role of microRNAs in the Development of Type 2 Diabetes Complications
Current Pharmaceutical Design Lung Transplantation: The Role of Azithromycin in the Management of Patients with Bronchiolitis Obliterans Syndrome
Current Medicinal Chemistry Accessing Targeted Nanoparticles to the Brain: The Vascular Route
Current Medicinal Chemistry Towards More Efficient Glutathione Peroxidase Mimics: Substrate Recognition and Catalytic Group Assembly
Current Medicinal Chemistry OPA1 in Cardiovascular Health and Disease
Current Drug Targets Effect of TRAF1 on Phenotypic Changes Of Kupffer Cells In Liver Transplantation Ischemic-Reperfusion
Current Pharmaceutical Biotechnology Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Treating Neonatal Brain Injury - Promise and Inherent Research Challenges
Recent Patents on Inflammation & Allergy Drug Discovery Lipids, Statins and Heart Failure: An Update
Current Pharmaceutical Design The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases
Current Drug Metabolism Differential Role of Apoptosis and Autophagy Associated with Anticancer Effect of Lupulone (Hop β-Acid) Derivatives on Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design